Streamlining Urology Waystar Clearinghouse Workflows with Prior Authorization Automation

Klivira enhances **urology Waystar clearinghouse** operations by automating prior authorizations, ensuring clean claims and accelerating revenue cycles for complex urologic care.

Revenue cycle leaders and prior authorization teams in urology face unique challenges, from the high volume of specialty drug PAs to urgent cancer care timelines. While Waystar efficiently manages claims and RCM as a clearinghouse and RCM platform, the upstream prior authorization process can introduce significant delays and denials. Automating these critical steps is essential for maximizing Waystar's effectiveness and maintaining financial health.

The Intersection of Urology Prior Authorization and Waystar RCM

Urology practices manage a diverse range of high-cost treatments, including advanced prostate cancer therapeutics, complex surgical procedures like robotic prostatectomy, and specialized imaging. Each often requires prior authorization, generating a heavy administrative burden. Integrating a robust PA automation solution upstream ensures that claims submitted through Waystar are pre-approved, minimizing rejections and accelerating the entire revenue cycle.

Key Prior Authorization Triggers in Urology

Navigating Documentation and Clinical Guidelines for Waystar Readiness

Accurate documentation is paramount for successful urology PAs and subsequent clean claims via Waystar. Payers frequently require adherence to AUA Clinical Practice Guidelines and NCCN Guidelines for urologic oncology. This includes specific data points like Gleason score, PSA levels, IPSS scores, prostate size, prior medical therapy trials, and biochemical recurrence details. Ensuring this clinical evidence is systematically collected and submitted with the PA request is vital for avoiding denials and streamlining the Waystar claims process.

Common Urology PA Denials Impacting Waystar Workflows

Klivira's Role in Optimizing Urology PA for Waystar Integration

Klivira's platform directly addresses the complexities of urology prior authorizations, complementing Waystar's robust revenue cycle management. By automating the evidence collection and submission process, Klivira ensures that all necessary clinical documentation—aligned with AUA and NCCN guidelines—is present for high-volume PA categories. This proactive approach reduces the administrative burden, minimizes denial rates, and delivers pre-approved claims to Waystar, accelerating payment cycles and improving financial outcomes for urology practices.

Seamless EMR and Payer Connectivity for Urology Revenue Cycles

Effective integration between EMRs, prior authorization platforms, and clearinghouses like Waystar is critical. Klivira integrates with leading EMRs via SMART on FHIR, extracting relevant patient data and clinical notes to populate PA requests. This ensures that the structured data required for X12 278 transactions and payer portal submissions is accurate and complete, feeding a clean data stream into Waystar for final claims processing. This integrated ecosystem streamlines the entire patient journey from clinical order to reimbursement.

Frequently asked questions

How does Klivira improve the Waystar clearinghouse experience for urology practices?

Klivira automates the prior authorization process upstream, ensuring that claims submitted to Waystar are pre-approved and clinically justified. This significantly reduces the likelihood of Waystar flagging claims for PA issues, minimizing rejections, accelerating claims processing, and improving overall revenue cycle efficiency for urology services.

Can Klivira handle the specific documentation requirements for prostate cancer PAs?

Yes, Klivira's platform is designed with urologic oncology in mind. It incorporates logic to gather specific documentation such as Gleason scores, PSA levels, prior treatments, and NCCN-compendium-supported indications, which are crucial for advanced prostate cancer drug authorizations. This ensures adherence to payer guidelines and clinical frameworks.

What types of urology procedures and drugs does Klivira automate prior authorizations for?

Klivira automates PAs for a wide range of urology services, including high-cost BPH/OAB drugs, prostate cancer therapeutics, minimally invasive BPH procedures (e.g., UroLift, Aquablation), robotic surgeries, and advanced imaging like PSMA PET scans. The platform is configured to handle the specific requirements for these high-volume categories.

How does Klivira address common urology PA denials like step therapy or medical necessity?

Klivira's intelligent policy engine identifies step therapy requirements upfront, guiding staff to document prior trials or exceptions. For medical necessity, it prompts for specific clinical evidence (e.g., IPSS scores, PSA trends, NCCN guidelines) to build a robust authorization request, proactively addressing common denial reasons before submission.

Is Klivira compatible with our existing EMR and Waystar setup?

Klivira is designed for seamless integration with major EMR systems using standards like SMART on FHIR. Our platform complements your existing Waystar clearinghouse setup by ensuring that prior authorizations are completed accurately and efficiently, providing Waystar with clean, pre-approved claims for optimal revenue cycle performance.

Related coverage

Other urology prior auth workflows

Ready to automate this workflow for this specialty?

See how Klivira automates prior authorizations for your team.

Request a demo